ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments - Seite 3

This partnership is a key development in tackling the growing data volumes faced by the healthcare and life sciences industries today. With the global AI market forecasted to exceed $1.3 trillion by 2032, the collaboration between InterSystems and IPA demonstrates their dedication to innovation, excellence, and the creation of solutions that not only address current industry needs but also anticipate future challenges.

Contact:

[e-mail]

SOURCE: ImmunoPrecise Antibodies Ltd.

View the original press release on accesswire.com


The ImmunoPrecise Antibodies Stock at the time of publication of the news with a fall of -0,39 % to 1,285EUR on Lang & Schwarz stock exchange (12. April 2024, 14:59 Uhr).